期刊文献+

胃癌外周血TWA1 mRNA的表达与预后价值

Predictive study of TWA1 mRNA expression in peripheral blood on the prognosis of patients with gastric cancer
原文传递
导出
摘要 目的检测胃癌(GC)患者外周血TWA1 mRNA表达水平,分析其与患者长期预后的关系。方法选择2016年6月至2017年6月于西宁市第二人民医院诊治的97例GC患者,实时荧光定量PCR(RT-PCR)检测外周血TWA1表达量,随访并记录患者无进展生存期(PFS)。受试者工作特征(ROC)曲线判定TWA1 mRNA的阈值,分组比较TWA1 mRNA不同表达患者的PFS情况。Cox回归模型评估TWA1 mRNA水平对GC患者预后的预测价值。结果随访(20.91±5.76)个月,随访率为94.79%(91/94),平均PFS(21.83±5.13)个月。TWA1 mRNA对GC患者PFS判定的曲线下面积为0.781(95%CI:0.687~0.875,P<0.001),截断值为1.27。TWA1 mRNA高表达患者的PFS显著短于低表达患者(χ~2=14.415,P<0.01)。淋巴结转移(HR=3.328,95%CI:2.098~5.971,P=0.044)、TNMⅢ~Ⅳ期(HR=3.400,95%CI:1.114~4.795,P=0.011)及外周血TWA1 mRNA高表达(HR=7.429,95%CI:1.711~32.263,P=0.007)是影响患者PFS的独立危险因素。结论外周血TWA1的表达与GC患者PFS显著相关,TWA1 mRNA水平对GC患者随访预后情况具有较好的预测价值。 Objective To investigate the predictive value of peripheral blood TWA1 mRNA expression on the prognosis of patients with gastric cancer(GC).Methods A total of 97 GC patients treated in the Second People’s Hospital of Xining City from June 2016 to June 2017 were selected,and the TWA1 expression in peripheral blood was detected by real-time fluorescent quantitative PCR(RT-PCR).Patients were followed up and recorded for progression-free survival(PFS).The ROC curve was used to determine the threshold of peripheral blood TWA1 mRNA for PFS in GC patients.PFS of patients with different expression of TWA1 mRNA was compared.Finally,Cox regression analysis was used to analyze the influencing factors of patients’PFS.Results The average follow-up time of all patients was(20.91±5.76)months,the follow-uprate was 94.79%with an average PFS of(21.83±5.13)months.The AUC for PFS of GC patients by TWA1 mRNA was 0.781(95%CI:0.687-0.875,P<0.001),and the Cut-off value was 1.27.PFS in patients with high TWA1 mRNA expression was significantly shorter(χ~2=14.415,P<0.01).Lymph node metastasis(HR=3.328,95%CI:2.098-5.971,P=0.044),TNMⅢ-Ⅳ(HR=3.400,95%CI:1.114-4.795,P=0.011),and high expression of TWA1 mRNA in peripheral blood(HR=7.429,95%CI:1.711-32.263,P=0.007)were independent risk factors for PFS.Conclusion The expression of TWA1 in peripheral blood has a significant effect on the prognosis of GC patients,which has good predictive value for the prognosis ofGC patients.
作者 程世芳 毛永芸 唐生业 侯志斌 Cheng Shifang;Mao Yongyun;Tang Shengye;Hou Zhibin(Department of Pathology,the Second People’s Hospital of Xining City,Xining 810003,China)
出处 《中华普通外科学文献(电子版)》 2020年第6期421-424,共4页 Chinese Archives of General Surgery(Electronic Edition)
关键词 胃肿瘤 TWA1 E3泛素连接酶复合物 预后 预测价值 Stomach neoplasms TWA1 E3 ubiquitin ligase complex Prognosis Predictive value
  • 相关文献

参考文献3

二级参考文献75

  • 1Hyung-SikLee,YoungminChoi,Won-JooHur,Hyo-JinKim,Hyuk-ChanKwon,Sung-HyunKim,Jae-SeokKim,Jong-Hoon Lee,Ghap-JoongJung,Min-ChanKim.Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine[J].World Journal of Gastroenterology,2006,12(4):603-607. 被引量:10
  • 2Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 3Jacques Chipponi,Michel Huguier,Denis Pezet,Nicolas Basso,Jean-Marie Hay,Pierre Quandalle,Daniel Jaeck,Pierre-Louis Fagniez,Alain Gainant.Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer[J].The American Journal of Surgery.2004(3)
  • 4E. Mari,I. Floriani,A. Tinazzi,A. Buda,M. Belfiglio,M. Valentini,S. Cascinu,S. Barni,R. Labianca,V. Torri.Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials[J].Annals of Oncology.2000(7)
  • 5Stephen R. Smalley,Jacqueline K. Benedetti,Daniel G. Haller,Scott A. Hundahl,Norman C. Estes,Jaffer A. Ajani,Leonard L. Gunderson,Bryan Goldman,James A. Martenson,J. Milburn Jessup,Grant N. Stemmermann,Charles D. Blanke,John S. Macdonald.Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection[J].Journal of Clinical Oncology.2012(19)
  • 6Trevor Leong,David Willis,Daryl Lim Joon,Sara Condron,Andrew Hui,Samuel Y.K. Ngan.3D Conformal radiotherapy for gastric cancer—results of a comparative planning study[J].Radiotherapy and Oncology.2005(3)
  • 7Jee Suk Chang,Joon Seok Lim,Sung Hoon Noh,Woo Jin Hyung,Ji Yeong An,Yong Chan Lee,Sun Young Rha,Chang Geol Lee,Woong Sub Koom.Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: Implications for postoperative radiotherapy[J].Radiotherapy and Oncology.2012(3)
  • 8Vivian E. Strong,Kyo Young Song,Cho Hyun Park,Lindsay M. Jacks,Mithat Gonen,Manish Shah,Daniel G. Coit,Murray F. Brennan.Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram[J]. Annals of Surgery . 2010 (4)
  • 9Sung Hoon Noh,Sook Ryun Park,Han-Kwang Yang,Hyun Cheol Chung,Ik-Joo Chung,Sang-Woon Kim,Hyung-Ho Kim,Jin-Hyuk Choi,Hoon-Kyo Kim,Wansik Yu,Jong Inn Lee,Dong Bok Shin,Jiafu Ji,Jen-Shi Chen,Yunni Lim,Stella Ha,Yung-Jue Bang.Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial[J]. Lancet Oncology . 2014 (12)
  • 10Yung-Jue Bang,Young-Woo Kim,Han-Kwang Yang,Hyun Cheol Chung,Young-Kyu Park,Kyung Hee Lee,Keun-Wook Lee,Yong Ho Kim,Sang-Ik Noh,Jae Yong Cho,Young Jae Mok,Yeul Hong Kim,Jiafu Ji,Ta-Sen Yeh,Peter Button,Florin Sirzén,Sung Hoon Noh.??Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial(J)The Lancet . 2012 (9813)

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部